Trial Profile
Retrospective study of solid tumor patients with hypercalcemia and their response to bisphosphonates or denosumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Hypercalcaemia
- Focus Therapeutic Use
- 19 Jan 2018 New trial record